The results of short-term supplementation studies are primarily responsible for the belief that LC supplementation does not affect metabolism
A September 2022 study of 127 adults published in the journal JCI Insight suggested that people with both obesity and alcohol use disorder who were treated with a GLP-1 drug called exenatide (Byetta, Bydureon) drank dramatically less than those who received only a placebo drug
Although peptides like BPC 157 are not yet FDA-approved, we are seeing promising results in patients seeking relief from a variety of injuries, chronic pain, and inflammation
Extensior 0.25mg Injection Combipack Dosage What is Extensior 0.25mg Injection Extensior 0.25 mg Injection improves glycemic control in adults with Type 2 Diabetes and supports weight management in overweight or obese individuals
Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort
Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo